The General Directorate of Medicines has ordered the suspension of the sale of these drugs, which can lead to cancer.
The National Medicines Agency (DNM) has suspended from February the principles of commercialization and consumption of oral medicines that contain the active principle of ranitidina.
The ranitidina has been used to treat peptic acidosis: acidosis, gastritis, gastric ulcer, esophageal reflux, among others.
The Director Ejecutivo de la DNM, Francisco Cortez Morales, a journey of a memorandum fechado 2 of February 2021, notice Ministro de Salud, Francisco Alabí, who decided to a rais de que tanto la Administración de Alimentos en Medicamentos de Estados Unidos (FDA, by its seal in English) as the European Medicines Agency (EMA, same case) will issue a sanitary alert in relation to its active principle.
According to Cortez Morales, the organisms are established under normal conditions of maintenance, and at higher temperatures than the manufacturer’s requirements, the levels of N-Nitrosodimethylamine (NDMA) in the raninidina are increased. expenditures to the higher levels of NDMA to the acceptable during a long period of time.
Podrías leer: Pharmacists who buy the Gobierno for patients with COVID-19 incremental risk to people with cardiac diseases
The DNM does not only inform you that it has withdrawn from the Sale of Medicines List of its medicines, but that, in addition, it will carry out vigilance regarding the sale of these products; We will also notify healthcare professionals about the new provision, which will provide its patients with other alternative therapies.
The DNM does not only inform you that it has withdrawn from the Sale of Medicines List of its medicines, but that, in addition, it will carry out vigilance regarding the sale of these.
“It is not uncommon to see that this drug does not affect drug abstinence, given that there are other drugs on the market, with other active principles, that have the same therapeutic indications as omeprazole, pantoprazole or lansoprazole; and the antagonists of the H2 receptors, like the famotidina ”, signaled the DNM.
Oncologist Raúl Lara said that in effect the rancid “is suspended from time to time by the FDA, then in high doses and most discretionary tumors have increased cancerous growths” cancerous.
According to Lara, in other countries this pharmacy is easily supported by others that are available in pharmacies and hospitals.
Aanbeveling: The drug addict against COVID-19 that reduces the risk of mortality
For the doctor Carlos Ramos Hinds, the media report by the DNM is ascertained, “because it appears that due to inadequate assessment topics the podium generates a compound that has been shown to be cancerous”.
Ramos Hinds explained that it was received as an antidote to attend to peptic ulcer disease problems, and coincided with the fact that there are other options in the market.
With this medium, as indicated, it can minimize the risk of exposure of the population to its component.
Dr. Ricardo Lara, salubrista, confirmed that the DNM’s note regarding drug treatment was agreed to be shared with the medical staff, although it was not shown in the media agreement.
In agreement with the external issue of the galeno, there is a tendency for the population to be affected by the widespread incontinence that has been consulted on asthma problems, caesarean section on the use of alternative medicines, which in most cases of a try.
The drug has been used to treat problems such as gastritis, esophageal reflux, among others. Medida is to avoid the risk of developing cancer.
The DNM distributes the line items to withdraw the drug